Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001415889-22-009350 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-06 | 2022-09-02 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | — | +1,725 | 36.8K | +5% | — |
| D | 2022-09-06 | 2022-09-02 | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $11.44 | -507 | 36.3K | -1% | -$5,800 |
| D | 2022-09-06 | 2022-09-02 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -1,725 | 5,175 | -25% | $0 |
| DM | 2022-09-06 | 2022-09-01 | KNSA | Paolini John F. | Chief MEDICAL Off | A - Grant | $0.00 | +69.9K | 59.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2022-09-02 | M | A | 1,725 | — | 36,842 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Common | Class A Common Share | 2022-09-02 | F | D | 507 | $11.44 | 36,335 | D | — | — | |
| 3 | Derivative | Restricted Share Unit | 2022-09-02 | M | D | 1,725 | $0.00 | 5,175 | D | — · — to — | 1,725 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. |
| 4 | Derivative | Restricted Share Unit | 2022-09-01 | A | A | 9,990 | $0.00 | 9,990 | D | — · — to — | 9,990 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |
| 5 | Derivative | Share Option | 2022-09-01 | A | A | 59,930 | $0.00 | 59,930 | D | $11.97 · — to 2032-08-31 | 59,930 Class A Common Share | (F2) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022. |